Prognostic significance of TGFβ1 and TGFβ3 in human breast carcinoma

Anticancer Research

Volumn 20, Issue 6 B, 2000, Pages 4413-4418

  Ghellal, A ^a   Li, C ^a   Hayes, M ^a   Byrne, G ^a   Bundered, N ^a   Kumar, S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Breast carcinoma; Immunohistochemistry; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLOOD LEVEL; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; PLEIOTROPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADULT; AGED; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0034480070     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells
2. Physiological actions and clinical applications of transforming growth factor-β (TGFβ)
3. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
4. Molecular and cell biology of TGFβ
5. Transforming growth factor β: Vasculogenesis, angiogenesis, and vessel wall integrity
6. Vascular cell apoptosis: Cell type-specific modulation by transforming growth factor-β1 in endothelial cells versus smooth muscle cells
7. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1
8. Localization of transforming growth factor-β1, -β2 and -β3 gene expression in bovine mammary gland
9. Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development
10. Mammary tumor suppression by transforming growth factor β1 transgene expression
11. Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation
12. Angiogenesis in breast cancer: The role of transforming growth factor β and CD105
13. Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells
14. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis
15. TGF-β isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis
16. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer
17. Transforming growth factor β1 in ductal carcinoma in situ and invasive carcinoma of the breast
18. Relationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma
19. Regulation and role of TGFβ production in breast cancer
20. The role of transforming growth factor β3 in lymphatic metastasis in breast cancer
21. Expression of transforming growth factor-β (TGF-β) isoforms in osteosarcomas
22. Long-term expression of transforming growth factor TGFβ1 in mouse skin after localized β-irradiation
23. Transforming growth factor β3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling
24. Neutralization of TGFβ1 and TGFβ2 or exogenous addition of TGFβ3 to cutaneous rat wounds reduces scarring
25. Prognostic significance of TGFβ1 and TGFβ2 expression in female breast cancer
26. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1
27. The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-β1 in metastatic human breast cancer: An immunocytochemical study